Active ingredient
Crizotinib
5 finished FDA listings contain Crizotinib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- CRIZOTINIB
- Dosage forms
- Capsule, Capsule, Coated Pellets
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 150 mg/1 · 20 mg/1 · 200 mg/1 · 250 mg/1 · 50 mg/1
- Brand names in FDA listings
- Xalkori
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1148495
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 202570 | PF PRISM CV | 2011-08-26 | 2 |
| NDA 217581 | PF PRISM CV | 2023-09-07 | 3 |
Official labeling on DailyMed
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.